SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)

Market Cap	4.28B
Revenue (ttm)	1.22B
Net Income (ttm)	327.48M
Shares Out	44.59M
EPS (ttm)	7.33
PE Ratio	13.09
Forward PE	n/a
Dividend	3.50 (3.65%)
Ex-Dividend Date	n/a

Volume	34,456
Average Volume	47,638
Open	95.60
Previous Close	95.90
Day's Range	95.30 - 95.90
52-Week Range	81.70 - 106.50
Beta	0.11
RSI	62.29
Earnings Date	Mar 7, 2025

About SYN-TECH Chem. & Pharm.

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, antiulcerative, antihypertensive, α- blocker, vasodilator, bronchodilator, anxiolytic, tranquilizer, local anest...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1982
• Employees: 220
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1777

Financial Performance

In 2023, SYN-TECH Chem. & Pharm.'s revenue was 1.11 billion, an increase of 13.02% compared to the previous year's 986.30 million. Earnings were 251.01 million, a decrease of -14.99%.